Kim Schmid concentrates her national litigation practice on defending high-profile manufacturers of medical devices, pharmaceuticals and nutraceuticals against product liability claims in courtrooms across the country. Kim defends her life-sciences clients in individual lawsuits, mass torts, multidistrict litigation and class actions. She recently tried and led the defense team on the first bellwether case in the California infusion pump JCCP to go to trial. Kim currently serves as National Coordinating Counsel in several medical device mass torts.
In court, Kim has extensive experience defending drug and medical device products, including latex gloves, breast implants, hip stem implants, oral contraceptives, cold therapy units, nutritional supplements, infusion pumps, orthopedic devices, implantable cardiac care devices, suction devices, surgical instruments, device monitors, blood warming units and more. She has defended IDE products utilized in clinical trials, as well as Class I, II and III FDA cleared devices. Kim has also defended pharmaceutical cases involving generics, branded, OTC and Rx medications.
A nationally recognized lawyer, Kim has authored key articles published in leading life-sciences journals and presents at national seminars on issues such as preemption, FDA regulatory oversight, clinical trials, product recall management, mass torts, bellwether selections, crisis management, and successful Daubert challenges and other evidence-based motions. She is also a member of the firm's Executive Committee, where she has leadership responsibility for strategic and overall firm management.